Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 study
Titel:
Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 study
Auteur:
Gregory, Gareth P. Kumar, Shaji Wang, Ding Mahadevan, Daruka Walker, Patricia Wagner-Johnston, Nina Escobar, Carolina Bannerji, Rajat Bhutani, Divaya Chang, Julie Hernandez-Ilizaliturri, Francisco J. Klein, Andreas Pagel, John M. Rybka, Witold Yee, Andrew J. Mohrbacher, Anne Huang, Mo Farooqui, Mohammed Marinello, Patricia Quach, Hang